Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis.
Georgios N
GN
Kalambokis
Epameinondas V
EV
Tsianos
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000503:physiopathology*; D004731:Endotoxins / Q000502:physiology*; D006801:Humans
D004731:Endotoxins